Corporate Overview
BioAgri is a biotechnology company capitalizing on the latest transgenic animal technology: linker based sperm-mediated gene transfer (LB-SMGT). LB-SMGT is a simpler and less expensive method to make transgenic animals and genetically engineered human stem cells for the benefit of medicine and agriculture. Our business will target three enormous multi-billion-dollar markets: (a) Biopharmacy (b) Agriculture, and (c) Human Gene Therapy and DNA Vaccines. 

We are headquartered in Los Angels, California, USA, and have a small number of facilities for transgenic farm animal development. A cGMP manufacturing plant to make human therapeutic proteins from SPF transgenic chicken eggs is under construction.